HYDROmorphone in dextrose 5% — Class II drug recall D-1049-2023
Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-08-09, distributed nationwide. Lack of assurance of sterility: Lack of validation data for sanitization cycles
| Recall number | D-1049-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Central Admixture Pharmacy Services Inc, San Diego, CA, United States |
| Recall initiated | 2023-07-17 |
| Classified | 2023-08-03 |
| Reported by FDA | 2023-08-09 |
| Terminated | 2025-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 2,228 syringes |
| Reason classes | sterility |
| NDC | 71286-2013-02 |
| Lot numbers | 17-270675, 17-270683, 17-271119, 17-271147, 17-271339, 17-271679, 17-272202, 17-272241, 17-272375, 17-272783, 17-273431, 17-273438, 17-273615, 17-273789 |
| Expiration dates | 2023-07-18, 2023-07-25, 2023-07-27, 2023-08-02, 2023-08-10, 2023-08-13, 2023-08-15, 2023-08-22, 2023-09-03, 2023-09-05 |
Product
HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2
Reason for recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1049-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.